Dysfunction of synaptic plasticity leads to memory impairment in Alzheimer’s disease (AD). Muscone (Mus) has shown neuroprotective effects in cerebral ischemic models. However, little is known of Mus effects on AD.
Objective:
To investigate the effects of Mus on memory functions and synaptic plasticity in 6-month-old APP/PS1 double-transgenic mice and explore the potential mechanisms.
Methods:
Mus was intraperitoneally injected into APP/PS1 or wild-type mice, and cognitive function was assessed by Novel object recognition and Morris water maze tests. The levels of amyloid-β (Aβ) were evaluated by immunofluorescence staining and ELISA. Synaptic morphology and plasticity were evaluated by Golgi staining and long-term potentiation. Cell viability was examined by Cell Counting Kit-8 assay. The protein levels of histone deacetylase 2 (HDAC2) were accessed by western blotting and Immunofluorescence staining. The protein levels of microtubule associated protein 2 and synaptophysin were analyzed by immunofluorescence staining. The ubiquitination of HDAC2 was examined by co-immunoprecipitation. The interaction of Mus with HDAC2 was predicted by molecular docking analysis.
Results:
Mus treatment attenuated memory dysfunction, reduced Aβ level, and enhanced synaptic plasticity in APP/PS1 mice. In addition, Mus treatment decreased the level of HDAC2 in the hippocampus of APP/PS1 mice and Aβ1–42-induced primary neurons, which might be associated with increased HDAC2 ubiquitination induced by HDAC2 and Mus interaction.
Conclusion:
Mus protected against synaptic plasticity and memory impairment in APP/PS1 mice, and enhanced HDAC2 degradation via ubiquitination, indicating that Mus was a potential drug for AD treatment.
OssenkoppeleR, PijnenburgYA, PerryDC, Cohn-SheehyBI, ScheltensNM, VogelJW, KramerJH, van der VliesAE, La JoieR, RosenHJ, van der FlierWM, GrinbergLT, RozemullerAJ, HuangEJ, van BerckelBN, MillerBL, BarkhofF, JagustWJ, ScheltensP, SeeleyWW, RabinoviciGD (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain138, 2732–2749.
2.
ZetterbergH (2017) Review: Tau in biofluids - relation to pathology, imaging and clinical features. Neuropathol Appl Neurobiol43, 194–199.
GotzJ, ChenF, van DorpeJ, NitschRM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science293, 1491–1495.
5.
StancuIC, RisL, VasconcelosB, MarinangeliC, GoeminneL, LaporteV, HaylaniLE, CouturierJ, SchakmanO, GaillyP, PierrotN, Kienlen-CampardP, OctaveJN, DewachterI (2014) Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease. FASEB J28, 2620–2631.
6.
Sanchez-RodriguezI, DjebariS, Temprano-CarazoS, Vega-AvelairaD, Jimenez-HerreraR, Iborra-LazaroG, YajeyaJ, Jimenez-DiazL, Navarro-LopezJD (2020) Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity. J Neurochem153, 362–376.
7.
RyuJ, HongBH, KimYJ, YangEJ, ChoiM, KimH, AhnS, BaikTK, WooRS, KimHS (2016) Neuregulin-1 attenuates cognitive function impairments in a transgenic mouse model of Alzheimer’s disease. Cell Death Dis7, e2117.
8.
Spires-JonesT, KnafoS (2012) Spines, plasticity, and cognition in Alzheimer’s model mice. Neural Plast2012, 319836.
9.
NimmrichV, GrimmC, DraguhnA, BarghornS, LehmannA, SchoemakerH, HillenH, GrossG, EbertU, BruehlC (2008) Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci28, 788–797.
LambertMP, BarlowAK, ChromyBA, EdwardsC, FreedR, LiosatosM, MorganTE, RozovskyI, TrommerB, ViolaKL, WalsP, ZhangC, FinchCE, KrafftGA, KleinWL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A95, 6448–6453.
14.
LacorPN, BunielMC, FurlowPW, ClementeAS, VelascoPT, WoodM, ViolaKL, KleinWL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci27, 796–807.
15.
JagirdarR, DrexelM, KirchmairE, TasanRO, SperkG (2015) Rapid changes in expression of class I and IV histone deacetylases during epileptogenesis in mouse models of temporal lobe epilepsy. Exp Neurol273, 92–104.
16.
PelegS, SananbenesiF, ZovoilisA, BurkhardtS, Bahari-JavanS, Agis-BalboaRC, CotaP, WittnamJL, Gogol-DoeringA, OpitzL, Salinas-RiesterG, DettenhoferM, KangH, FarinelliL, ChenW, FischerA (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science328, 753–756.
17.
WalkerMP, LaFerlaFM, OddoSS, BrewerGJ (2013) Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer’s disease. Age (Dordr)35, 519–531.
LattalKM, BarrettRM, WoodMA (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci121, 1125–1131.
20.
VolmarCH, Salah-UddinH, JanczuraKJ, HalleyP, LambertG, WodrichA, ManoahS, PatelNH, SartorGC, MehtaN, MilesNTH, DesseS, DorciusD, CameronMD, BrothersSP, WahlestedtC (2017) M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory. Proc Natl Acad Sci U S A114, E9135–E9144.
21.
FrancisYI, FaM, AshrafH, ZhangH, StaniszewskiA, LatchmanDS, ArancioO (2009) Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer’s disease. J Alzheimers Dis18, 131–139.
McQuownSC, BarrettRM, MatheosDP, PostRJ, RoggeGA, AlenghatT, MullicanSE, JonesS, RuscheJR, LazarMA, WoodMA (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci31, 764–774.
24.
KimMS, AkhtarMW, AdachiM, MahgoubM, Bassel-DubyR, KavalaliET, OlsonEN, MonteggiaLM (2012) An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci32, 10879–10886.
25.
HawkJD, FlorianC, AbelT (2011) Post-training intrahippocampal inhibition of class I histone deacetylases enhances long-term object-location memory. Learn Mem18, 367–370.
26.
MillardCJ, WatsonPJ, FairallL, SchwabeJWR (2017) Targeting class I histone deacetylases in a “complex” environment. Trends Pharmacol Sci38, 363–377.
27.
SungYM, LeeT, YoonH, DiBattistaAM, SongJM, SohnY, MoffatEI, TurnerRS, JungM, KimJ, HoeHS (2013) Mercaptoacetamide-based class II HDAC inhibitor lowers Abeta levels and improves learning and memory in a mouse model of Alzheimer’s disease. Exp Neurol239, 192–201.
28.
GraffJ, ReiD, GuanJS, WangWY, SeoJ, HennigKM, NielandTJ, FassDM, KaoPF, KahnM, SuSC, SamieiA, JosephN, HaggartySJ, DelalleI, TsaiLH (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature483, 222–226.
29.
ChangWH, ChenMC, ChengIH (2015) Antroquinonol lowers brain amyloid-beta levels and improves spatial learning and memory in a transgenic mouse model of Alzheimer’s disease. Sci Rep5, 15067.
30.
YuanWX, WangXX, ZhengDH, MaD, CuiQ, YangF, ZhangJ (2019) Muscone promotes the adipogenic differentiation of human gingival mesenchymal stem cells by inhibiting the Wnt/beta-catenin signaling pathway. Drug Des Devel Ther13, 3291–3306.
31.
XuL, CaoY (2016) Native musk and synthetic musk ketone strongly induced the growth repression and the apoptosis of cancer cells. BMC Complement Altern Med16, 511.
32.
DuY, GuX, MengH, AaN, LiuS, PengC, GeY, YangZ (2018) Muscone improves cardiac function in mice after myocardial infarction by alleviating cardiac macrophage-mediated chronic inflammation through inhibition of NF-kappaB and NLRP3 inflammasome. Am J Transl Res10, 4235–4246.
33.
WeiG, ChenDF, LaiXP, LiuDH, DengRD, ZhouJH, ZhangSX, LiYW, LiH, ZhangQD (2012) Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway. Nat Prod Commun7, 1069–1074.
34.
WeiJ, YaoL, YangL, ZhaoW, ShiS, CaiQ, ChenD, LiW, WangQ (2015) Alteration of glutamate/GABA balance during acute alcohol intoxication in rats: effect of Xingnaojing injection. J Ethnopharmacol166, 333–339.
35.
Ben-AzuB, OmogbiyaIA, AderibigbeAO, UmukoroS, AjayiAM, IwalewaEO (2018) Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways. Brain Res Bull139, 114–124.
36.
ChenJ, ShuS, ChenY, LiuZ, YuL, YangL, XuY, ZhangM (2019) AIM2 deletion promotes neuroplasticity and spatial memory of mice. Brain Res Bull152, 85–94.
37.
YuL, LiuY, YangH, ZhuX, CaoX, GaoJ, ZhaoH, XuY (2017) PSD-93 attenuates amyloid-beta-mediated cognitive dysfunction by promoting the catabolism of amyloid-beta. J Alzheimers Dis59, 913–927.
GuoYJ, LuoSH, TangMJ, ZhouZB, YinJH, GaoYS, DangXQ (2018) Muscone exerts protective roles on alcohol-induced osteonecrosis of the femoral head. Biomed Pharmacother97, 825–832.
46.
WangGY, WangN, LiaoHN (2015) Effects of muscone on the expression of P-gp, MMP-9 on blood-brain barrier model in vitro. Cell Mol Neurobiol35, 1105–1115.
47.
WuS, WangN, HeQ, ChangG, SetoSW, ChangD, LiangH (2018) The establishment of the method of cell biochromatograpy and analysis of the active ingredients from TongQiaoHuoXue decoction acting on the neurocytes. Chem Pharm Bull (Tokyo)66, 983–991.
48.
TerryRD, MasliahE, SalmonDP, ButtersN, DeTeresaR, HillR, HansenLA, KatzmanR (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol30, 572–580.
49.
BorosBD, GreathouseKM, GentryEG, CurtisKA, BirchallEL, GearingM, HerskowitzJH (2017) Dendritic spines provide cognitive resilience against Alzheimer’s disease. Ann Neurol82, 602–614.
50.
Spires-JonesTL, HymanBT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer’s disease. Neuron82, 756–771.
51.
HenstridgeCM, PickettE, Spires-JonesTL (2016) Synaptic pathology: a shared mechanism in neurological disease. Ageing Res Rev28, 72–84.
52.
PhamE, CrewsL, UbhiK, HansenL, AdameA, CartierA, SalmonD, GalaskoD, MichaelS, SavasJN, YatesJR, GlabeC, MasliahE (2010) Progressive accumulation of amyloid-beta oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J277, 3051–3067.
53.
BayesA, van de LagemaatLN, CollinsMO, CroningMD, WhittleIR, ChoudharyJS, GrantSG (2011) Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci14, 19–21.
54.
WalshDM, KlyubinI, FadeevaJV, CullenWK, AnwylR, WolfeMS, RowanMJ, SelkoeDJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature416, 535–539.
KosikKS, RappPR, RazN, SmallSA, SweattJD, TsaiLH (2012) Mechanisms of age-related cognitive change and targets for intervention: epigenetics. J Gerontol A Biol Sci Med Sci67, 741–746.
57.
MontgomeryRL, HsiehJ, BarbosaAC, RichardsonJA, OlsonEN (2009) Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci U S A106, 7876–7881.
58.
YamakawaH, ChengJ, PenneyJ, GaoF, RuedaR, WangJ, YamakawaS, KritskiyO, GjoneskaE, TsaiLH (2017) The transcription factor Sp3 cooperates with HDAC2 to regulate synaptic function and plasticity in neurons. Cell Rep20, 1319–1334.
59.
IshizukaY, ShimizuH, TakagiE, KatoM, YamagataH, MikuniM, ShiraoT (2014) Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers. Neurochem Int76, 114–121.
60.
WuY, XuY, HuangX, YeD, HanM, WangHL (2018) Regulatory roles of histone deacetylases 1 and 2 in Pb-induced neurotoxicity. Toxicol Sci162, 688–701.
61.
WangDB, KinoshitaC, KinoshitaY, SopherBL, UoT, LeeRJ, KimJK, MurphySP, Dirk KeeneC, GardenGA, MorrisonRS (2019) Neuronal susceptibility to beta-amyloid toxicity and ischemic injury involves histone deacetylase-2 regulation of endophilin-B1. Brain Pathol29, 164–175.
62.
LiZ, HaoQ, LuoJ, XiongJ, ZhangS, WangT, BaiL, WangW, ChenM, WangW, GuL, LvK, ChenJ (2016) USP4 inhibits p53 and NF-kappaB through deubiquitinating and stabilizing HDAC2. Oncogene35, 2902–2912.
63.
ZhangJ, KanS, HuangB, HaoZ, MakTW, ZhongQ (2011) Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2. Genes Dev25, 2610–2618.
